ArticleIET systems biology
CAAFE-ResNet: A ResNet With Channel Attention-Augmented Feature Extraction for Prognostic Assessment in Rectal Cancer.
Article in IET systems biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Magnetic resonance imaging (MRI) has a pivotal role in both pretreatment staging and post-treatment evaluation of rectal cancer. This study presents an innovative deep learning model, CAAFE-ResNet18*, based on the residual neural network ResNet18*. The model features an ingeniously designed feature extraction and complementation module (i.e., CAAFE), which leverages a multiscale dilated convolution parallel architecture combined with a channel attention mechanism (CAM) to achieve multilevel information fusion, spatial feature enhancement and channel feature optimisation. This enables in-depth exploration and augmentation of multilevel downsampled features, significantly improving feature representation capability and overall performance. Testing on rectal cancer MRI data demonstrates that the CAAFE-ResNet18* model significantly outperforms convolutional neural network (CNN) backbone networks and recent state-of-the-art (SOTA) models. This result indicates that the CAAFE model, by complementing and extracting MR images of patients with locally advanced rectal cancer (LARC) features at different scales from ResNet18*, may help to identify patients who will show complete response (CR) at the end of treatment and those who will not respond to therapy (NR) at an early stage of the treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.